Not applicableStudy completedNCT04981249What this trial is testingChronic Multimorbidity Patterns in Relation to COVID-19 Severe InfectionWho this might be right forCovid-19Chronic Disease Corporacion Parc Tauli 14,286
Not applicableActive Not RecruitingNCT05467917What this trial is testingARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index CasesWho this might be right forCOVID-19HouseholdsSARS CoV 2 Infection Columbia University 374
Large-scale testing (Phase 3)Ended earlyNCT04695704What this trial is testingEfficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:Who this might be right forCovid19SARS (Disease) Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984What this trial is testingInvestigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.Who this might be right forCOVID-19 Inmunova S.A. 243
Not applicableLooking for participantsNCT04582903What this trial is testingSend-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and ConvalescenceWho this might be right forCOVID-19 Infection National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840What this trial is testingOpaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaWho this might be right forCOVID-19Lung Infection RedHill Biopharma Limited 475
Not applicableStudy completedNCT04610554What this trial is testingLung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19Who this might be right forCOVID-19 Pneumonia IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 74
Large-scale testing (Phase 3)Study completedNCT04397562What this trial is testingA Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19Who this might be right forCOVID-19 Biocad 206
Large-scale testing (Phase 3)WithdrawnNCT04575064What this trial is testingAn International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANYWho this might be right forSARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19 Professor Dr. Bernd Mühlbauer
Testing effectiveness (Phase 2)UnknownNCT04299152What this trial is testingStem Cell Educator Therapy Treat the Viral Inflammation in COVID-19Who this might be right forSevere Acute Respiratory Syndrome (SARS) Pneumonia Throne Biotechnologies Inc. 20
Large-scale testing (Phase 3)Study completedNCT04304053What this trial is testingTreatment of COVID-19 Cases and Chemoprophylaxis of Contacts as PreventionWho this might be right forCOVID-19 Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 2,300
Not applicableStudy completedNCT04490200What this trial is testingEffectiveness of a Novel Respirator With Chitosan NanoparticlesWho this might be right forCovid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare University of Brasilia 300
Testing effectiveness (Phase 2)Study completedNCT04710199What this trial is testingTrial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)Who this might be right forVirus Diseases Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44
Large-scale testing (Phase 3)Study completedNCT04510493What this trial is testingCanakinumab in Patients With COVID-19 and Type 2 DiabetesWho this might be right forCoronavirus InfectionDiabetes Mellitus, Type 2 University Hospital, Basel, Switzerland 116
Large-scale testing (Phase 3)Study completedNCT04346693What this trial is testingAn Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19Who this might be right forAcute Respiratory Tract InfectionAcute Respiratory InsufficiencyPneumonia+2 more Burnasyan Federal Medical Biophysical Center 320
Not applicableStudy completedNCT04583319What this trial is testingValidation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) InfectionWho this might be right forSARS-CoV Firalis SA 300
Not applicableStudy completedNCT05650944What this trial is testingHow Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?Who this might be right forCOVID-19 Hisar Intercontinental Hospital 125
Early research (Phase 1)Looking for participantsNCT07445971What this trial is testingA Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.Who this might be right forCOVID -19COVID-19 (Prevention) ModeX Therapeutics, An OPKO Health Company 80
Large-scale testing (Phase 3)UnknownNCT04780152What this trial is testingTDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 PandemicWho this might be right forMajor Depressive Disorder El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 172
Not applicableStudy completedNCT04885452What this trial is testingPrevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.Who this might be right forSARS-CoV InfectionCovid19 ANRS, Emerging Infectious Diseases 756